{"id":"W3031933721","doi":"10.1200/jco.2020.38.15_suppl.5007","title":"FRACTION-RCC: Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital; McMaster University; Juravinski Cancer Centre; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Discontinuation; Refractory (planetary science); Oncology; Renal cell carcinoma; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432405,0.0006423147,0.001174677,0.0004947874,0.0002676752,0.0009341594,0.0008426536,0.0005534497,0.002314013],"category_scores_gemma":[0.0007221059,0.0003442723,0.0008291384,0.0004823373,0.0003054142,0.0003687228,0.0003947144,0.0005653905,0.0005789748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001084904,"about_ca_system_score_gemma":0.001262406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002427475,"about_ca_topic_score_gemma":0.003397957,"domain_scores_codex":[0.9994614,0.0001371043,0.00002374748,0.0001593925,0.0001533177,0.00006508855],"domain_scores_gemma":[0.9997501,0.00004964801,0.00005519953,0.0000414018,0.00004084639,0.00006277311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.129275,0.02365316,0.0622833,0.002072609,0.00287835,0.0003179458,0.0002884418,0.03604892,0.4461687,0.0009714639,0.009918796,0.2861234],"study_design_scores_gemma":[0.04036606,0.2184229,0.1754043,0.0000966336,0.005006038,0.004138064,0.000251429,0.1469384,0.3782365,0.001435919,0.02943329,0.0002703633],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855421,0.003481056,0.00520032,0.0001434528,0.00004862667,0.0009630502,0.003016539,0.0003813712,0.001223493],"genre_scores_gemma":[0.9811262,0.0008672799,0.01179176,0.0001547565,0.00004560593,0.0005868679,0.004195224,0.00004186317,0.001190469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002427475,"threshold_uncertainty_score":0.007871628,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1384281087222637,"score_gpt":0.4579737183330004,"score_spread":0.3195456096107366,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}